Lipella Pharmaceuticals Inc. Common Stock (LIPO) — Financial Flexibility Index
Lipella Pharmaceuticals Inc. Common Stock (LIPO) has a Financial Flexibility Index of -2734.54x as of September 2025. Free cash flow of $-2.36 Billion (operating CF $-2.36 Billion minus capex $0.00) represents -2735% of total liabilities ($862.22K). Also explore Lipella Pharmaceuticals Inc. Common Stoc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lipella Pharmaceuticals Inc. Common Stock Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Lipella Pharmaceuticals Inc. Common Stock across 6 annual periods. Check asset allocation strategy of Lipella Pharmaceuticals Inc. Common Stoc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Lipella Pharmaceuticals Inc. Common Stock (2019–2024)
Year-by-year free cash flow to debt coverage for Lipella Pharmaceuticals Inc. Common Stock. For the full company profile including market capitalisation, see LIPO market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.24x | $-3.95 Million | $-3.95 Million | $754.42K | ▲ +27.7% |
| 2023 | -7.25x | $-3.14 Million | $-3.15 Million | $432.73K | ▼ -404.4% |
| 2022 | -1.44x | $-1.83 Million | $-1.83 Million | $1.27 Million | ▲ +14.4% |
| 2021 | -1.68x | $-989.27K | $-989.27K | $589.34K | ▼ -2788.3% |
| 2020 | -0.06x | $-28.58K | $-28.58K | $491.70K | ▲ +64.7% |
| 2019 | -0.16x | $-39.12K | $-39.12K | $237.26K | — |